IL-10 differentially controls the infiltration of inflammatory macrophages and antigen-presenting cells during inflammation by Liao, Chia-Te et al.





IL-10 differentially controls the infiltration
of inflammatory macrophages and antigen-presenting
cells during inflammation
Chia-Te Liao1, Marcela Rosas1, Luke C. Davies1, Peter J. Giles2,
Victoria J. Tyrrell1, Valerie B. O’Donnell1,3, Nicholas Topley3,
Ian R. Humphreys1,3, Donald J. Fraser1,3, Simon A. Jones1,3
and Philip R. Taylor1,3
1 Division of Infection and Immunity, Cardiff University School of Medicine, Heath Park,
Cardiff, UK
2 Central Biotechnology Services, Cardiff University School of Medicine, Heath Park, Cardiff,
UK
3 Systems Immunity University Research Institute, Cardiff University School of Medicine,
Heath Park, Cardiff, UK
The inflammatory activation and recruitment of defined myeloid populations is essen-
tial for controlling the bridge between innate and adaptive immunity and shaping the
immune response to microbial challenge. However, these cells exhibit significant func-
tional heterogeneity and the inflammatory signals that differentially influence their effec-
tor characteristics are poorly characterized. In this study, we defined the phenotype
of discrete subsets of effective antigen-presenting cells (APCs) in the peritoneal cav-
ity during peritonitis. When the functional properties of these cells were compared to
inflammatory monocyte-derived macrophages we noted differential responses to the
immune-modulatory cytokine IL-10. In contrast to the suppressive actions of IL-10 on
inflammatory macrophages, the recruitment of APCs was relatively refractory and we
found no evidence for selective inhibition of APC differentiation. This differential response
of myeloid cell subsets to IL-10 may thus have limited impact on development of poten-
tially tissue-damaging adaptive immune responses, while restricting the magnitude of
the inflammatory response. These findings may have clinical relevance in the context
of peritoneal dialysis patients, where recurrent infections are associated with immune-
mediated membrane dysfunction, treatment failure, and increased morbidity.
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Introduction
Local immunity in the peritoneal cavity contributes to the failure
of peritoneal dialysis (PD) as a treatment for end-stage kidney
disease. In this context, peritoneal infection is a major driver,
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together with inflammation-driven fibrosis that leads to peritoneal
membrane dysfunction and, in a minority of cases, a severe encap-
sulating peritoneal sclerosis [1–3]. Positive outcome of infectious
peritonitis in PD patients is associated with Th1-like responses
[4] and we recently demonstrated a role for IL-6/IFNγ/STAT1-
dependent adaptive immunity in the development of fibrotic tis-
sue damage following recurrent peritonitis [5]. However, limited
information is currently available on the innate sensing cells that
control these downstream adaptive immune responses and control
of local immune responses could feasibly alleviate tissue damage.
Peripheral tissues contain discrete populations of tissue resi-
dent (Res)macrophages (MØ) and dendritic cells (DC), which play
fundamental roles in tissue homeostasis and immune-surveillance
[6–9]. In spite of the importance of peritoneal immune alterations
in the efficacy of PD and potentially in other conditions, peri-
toneal antigen presenting cells (APCs) are very poorly character-
ized [10]. In addition, intense historical study of ‘peritoneal MØ’
has largely neglected the phenotypic heterogeneity of these cells,
with potential ramifications for understanding many aspects of
basic immune-biology of the tissue, such as which are the key
antigen presenting cells within the tissue.
We previously demonstrated in the peritoneum of na¨ıve
mice, cells with an F4/80int-lowCD11cint-lowMHCIIhighCD116high
CD206high12/15-lipoxygenase– phenotype [11, 12]. We tenta-
tively classified these cells ‘DC-like’ because they mounted effec-
tive inflammatory responses [11, 13], presented antigen to na¨ıve
CD4+ T cells, and were efficient IL-12 producers. However, during
experimental peritonitis we were unable to distinguish the ‘DC-
like’ cells from inflammatory monocyte-derived (Inf) MØ [11].
The presence of these MHCIIhigh ‘DC/MØ-like’ cells has been con-
firmed [14, 15], however, critically, the failure to identify them
in inflammation has led to ambiguity, and confusion of these cells
with InfMØ and possibly also with DC [15, 16].
We now define specific peritoneal MHCIIhigh ‘DC/MØ-like’ sub-
sets and distinguish them from InfMØ. Contrary to recent sugges-
tions [15], the recruitment of these cells was more resistant to
the anti-inflammatory actions of IL-10 than contemporary InfMØ.
Collectively, our data indicate that effective antigen processing
and presentation is restricted to discrete subsets of peripherally-
recruited monocyte-like cells and identifies differential control of
MØ and APC recruitment by IL-10, which has marked implications
for understanding the peritoneal immunity and the tissue damag-
ing adaptive responses that evolve during peritoneal dialysis.
Results
Identification of peritoneal APC subsets
Myeloid cells in the peritoneal cavity are differentially charac-
terized by expression of CD11b and F4/80 [11, 14]. We previ-
ously considered a minor population with CD11bintF4/80int-low
MHCIIhighCD11cint-low phenotype ‘DC-like’ because of their abil-
ity to present antigen to na¨ıve T cells [11]. To discriminate
these cells from monocyte-derived InfMØ during inflamma-
tion, published microarray data that compared peritoneal
‘F4/80lowMHCII+’ (a most-likely mixed population contain-
ing the peritoneal APC) with ‘F4/80intMHCII+’ InfMØ during
thioglycollate-induced peritonitis were analyzed for differences
(Supporting Information Table 1) [17]. F4/80lowMHCII+ cells
were associated with higher expression of CD226 (DNAM-1, DNAX
accessory protein-1) (Fig. 1A). Polychromatic flow-cytometric
analysis failed to identify a discrete subset of cells, but the majority
of cells exhibited moderate or greater staining for CD11c and/or
CD226 and could be readily identified throughout an acute inflam-
matory episode (Fig. 1A). ResMØ and putative APC were purified
from na¨ıve animals (Fig. 1B, Methods). All cells were morpholog-
ically myeloid, however, the CD11c+CD226low cells were smaller
in size with less cytoplasm.
APC kinetics during SES-induced peritonitis
In the acute Staphylococcus epidermidis cell-free supernatant
(SES)-induced and zymosan-induced sterile peritonitis mod-
els [18–20], neutrophils (CD11b+F4/80–Ly6G+) are rapidly
recruited into the peritoneal cavity during the first few hours,
but numbers subside after 24 h [18–20] (Fig. 1C). In con-
trast, the numbers of ResMØ decline initially and recover
during the resolution of inflammation [19, 20] (Fig. 1C).
InfMØ (CD11bintF4/80intCD11c–CD226–, Fig. 1A) accumulated
in the peritoneal cavity after SES or zymosan administra-
tion (Fig. 1C). Examination of the APC subsets (CD11clow
CD226+, CD11c+CD226+ and CD11c+CD226low cells) during the
inflammatory response (Fig. 1C), showed the numbers of CD11clow
CD226+ and CD11c+CD226low cells initially decreased following
peritonitis and then increased later during inflammation (Fig. 1C).
Origin of peritoneal antigen presenting cells
To determine whether the increased CD11clowCD226+ and
CD11c+CD226low numbers were due to the recruitment from the
periphery or local expansion, adoptive transfer experiments (Sup-
porting Information Fig. 1) and proliferation studies (Supporting
Information Fig. 2) were performed. These indicated that, in con-
trast to donor ResMØ, which remained relatively stable within the
tissue [20], the donor APC were lost from the tissue and replaced
by host cells. This result also reflected the relatively poor capacity
of the CD226 and CD11c expressing APC subsets to proliferate
during inflammation (Supporting Information Fig. 2), in contrast
to the recently described proliferative activity of ResMØ [19, 20].
Dendritic cell precursor fate-mapping and growth
factor dependency of peritoneal APCs
An experiment using mice lacking ligand for the receptor fms-
like tyrosine kinase 3 (Flt3l−/−), which is an important growth
factor for DC expansion in the BM, blood and peripheral
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Figure 1. Identification and inflammatory kinetics of peritoneal APCs. (A) Peritonitis was induced by intraperitoneal administration of cell-free
supernatant prepared from a clinical isolate of S. epidermidis. Flow-cytometric analysis showing the kinetic changes of ResMØ and APC during
SES-induced peritonitis [18]. Cells were first gated on single cell events (via FSCArea vs FSClinear profiles) and then the APC were gated on via their
characteristic F4/80, CD11b profiles (shown in the upper row). The middle and lower rows show comparisons of MHCII and CD226 respectively to
CD11c (B cells were confirmed to be excluded via CD19 staining). Last, the APC were subdivided with the aid of CD226 and CD11c expression (i.e.
they were CD19−CD11bintMHCII+ with CD11clow/−CD226+, CD11c+CD226+, or CD11c+CD226low/− phenotypes). Dot plots are from representative
mice from one of two independent experiments with 9–11 mice per experiment (B) ResMØ (CD19−CD11bhighMHCII−CD11clow/−CD226−) and the
three arbitrary subsets of APC defined above were purified based on these phenotypes (see methods for details) from cells pooled from 10 naı¨ve
C57BL/6 mice. The morphology of individual cell subsets on cytospin preparations is shown (scale bar represents 30 μm). Data are representative
of two independent experiments. (C) Graphs showing the absolute numbers of neutrophils (F4/80− Ly6G+), InfMØ (F4/80intCD11bintCD11c−CD226−),
ResMØ and the three subsets of APC (as defined above) during acute peritoneal inflammation induced with SES (blue), 2 × 106 (magenta) or 2 × 107
(orange) zymosan particles. Data (mean ± SEM) are derived from 5 to 6 week old C57BL/6 mice (n = 3–5 per group). Data from the SES model are
derived from one of two independent experiments (9 and 11 mice in total), while data from the zymosan peritonitis experiments are derived from
single experiments with a total of 12 and 13mice. Data were analyzed by two-way ANOVA (after log transformation in the case of neutrophils) with
Bonferroni posttests (color coded p value abbreviations relate to differences from time 0 h; p values are summarized as follows: *p < 0.05 and ***p <
0.001). The interaction statistic (Int) is indicated where significant; else the significance tests for time or inflammatory stimulus (Stim.) are shown.
lymphoid or non-lymphoid tissues [22], demonstrated a marked
deficiency of these peritoneal APC in the absence of Flt3l (Fig.
2). To further define the developmental origins of these peri-
toneal APC, DNGR-1-expressing cells were fate-mapped using
Clec9a+/CreRosa+/EYFP mice [21] to trace the DC lineage (common
DC precursors and their progeny). Multi-color flow cytometric
analysis delineated the distribution of YFP+ DC lineage within
the na¨ıve peritoneal cavity (Fig. 3) and the proportion of YFP+
cells in individual MØ/DC subset (Fig. 3). Compared to 90%
YFP+ in CD11b–CD103+ DC and <5% YFP+ in ResMØ, the three
APC subsets are around 20–40% YFP+ (CD11c+CD226low subset
is the highest one among them).
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Figure 2. Flt3 ligand dependency of peri-
toneal APCs. (A) The numbers of peritoneal
CD11b+MHCIIhigh DC-like cells from Flt3l-
deficient mice were analyzed by flow cytom-
etry. Density plots are pregated on single
cell CD11b+F4/80low/+ events, and are from an
experiment with 20 mice (5 mice per group).
(B) The relative defect in APC numbers was
quantified and expressed as a proportion of
CD11b+ cells (including ResMØ) (data shown
is mean±SEM are derived from an experiment
with 5mice per group). (C)Absolute numbers of
each myeloid subset in the same mice shown
in (B) were analyzed by two-way ANOVA and p
values are shown for the effects of Flt3l and sex
on myeloid subset numbers and for the exis-
tence of an interaction (Int) between these two
variables. n.s. denotes ‘not significant’.
Dependency of peritoneal APCs on CCR2
Since the CD226 and CD11c expressing APC uniformly expressed
CCR2, their numbers were examined and found to be markedly
reduced under both homeostatic and inflammatory conditions in
the absence of CCR2 (Fig. 4). The three APC populations were sig-
nificantly reduced in numbers in na¨ıve mice (Fig. 4A) and also in
mice experiencing zymosan peritonitis (Fig. 4B). This was in con-
trast to the presence of normal numbers of ResMØ in the absence
of CCR2 in both na¨ıve and inflamed conditions (Fig. 4), but similar
to the deficiency in inflammatory monocyte-derived MØ observed
during inflammation in the absence of CCR2 (Fig. 4B).
Phenotype and antigen presenting properties
of peritoneal APCs
When first reported, several markers were noted to be differen-
tially expressed between the bulk population of APC and the co-
existing ResMØ in na¨ıve mice (e.g. the mannose receptor CD206)
[11].While the CD11c+CD226low phenotype appears to define one
population of cells, neither CD11c nor CD209a allowed definitive
identification of discrete populations (Fig. 5A and B).
Both ResMØ and putative APC express CD80 and CD86
(Fig. 5B), however, only ResMØ expressed both of the proposed
‘MØ-markers’ CD64 (FcγR1) and MerTK [17] while CD11clow
CD226+ cells from na¨ıve animals did express MerTK (Fig. 5A).
Notably, only the putative APC express CD206 (macrophage man-
nose receptor) [11] and CCR2 (Fig. 5A) in na¨ıve animals. Of the
populations, CD11c+CD226low cells have more uniformly high
CD209a expression (Fig. 5A). A similar expression profile was
seen during inflammation (Supporting Information Fig. 3). Dur-
ing inflammation, the CD226+ subpopulations exhibited transient
Ly-6C expression (Supporting Information Fig. 4A). A selective
expansion of CD226+ cells was also observed in mice with a
myeloid Gata6-deficiency [23] (Supporting Information Fig. 4B).
Since CD226 high expression was associated with heterogeneous
expression of CD11c and CD209a it was pragmatic to continue
to divide them by surface antigen phenotype: CD11c+CD226+,
CD11clowCD226+ and CD11c+CD226lowcells.
Antigen processing and presentation by peritoneal
APCs
To determine if the putative APC were competent antigen pre-
senting cells and to ensure direct measurement of antigen pro-
cessing and not presentation of unprocessed ‘low quality’ antigen
preparations, a fresh egg white extract (EWE) as a source of oval-
bumin was prepared [24] (Fig. 5C). Bone marrow (BM)-derived
DC were used live or fixed in antigen presentation assays with
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Figure 3. Clec9a+/CreRosa+/EYFP mice define DC-
restricted YFP expression in the peritoneal
APC. Cells from the peritoneal cavity of
Clec9a+/CreRosa+/EYFP mice were analyzed for
EYFP expression by flow cytometry. A propor-
tion of cells derived from dendritic cell precur-
sors are labeled with EYFP at this precursor
stage, and the majority of CD103+ DC, which
are DNGR-1+, are similarly labeled. (A) Peri-
toneal EYFP+ cells were analyzed for CD11b,
CD103, F4/80, CD11b, CD226, and CD11c expres-
sion. Cells were first gated on single cell events,
before being sequentially gated as indicated
in the plots. Data are derived from an exper-
iment with four male and four female mice. (B)
Gating on the various myeloid subsets specif-
ically allowed quantification of the proportion
of EYFP-expressing cells in each compartment
(numbers indicate percentages in each region
of the annotated density plots). Dot plots in A
and B are representative mice from an exper-
iment with eight mice in total (4 male and 4
female) (C) Graphs, which represent the per-
centage of each cell type that is EYFP positive
in the mice shown in (B) above, demonstrate
EYFP in a significant proportion of all CD11b+
DC-like cell subsets, but not ResMØ.
EWE or commercial ovalbumin and specific T-cell hybridomas.
Commercial ovalbumin, but not EWE, could be presented by fixed
BMDC (Supporting Information Fig. 6), so EWE was used to assess
native antigen processing and presentation.
All putative APC processed EWE and presented to BO-97.11
CD4+ T cells, as determined by IL-2 production. (Fig. 5D). As
previously noted [11], the MHCIIlow/– ResMØ had no significant
activity in this assay.
IL-10 and the differential regulation of inflammatory
MØ and APC recruitment
IL-10 has recently been reported to control the differentiation
of peritoneal ‘DC-like’ cells during inflammation from peripheral
monocytes [15]. This study implied the MHCII+ inflammatory
cells were related to those found in the na¨ıve tissue, and proposed
a role for IL-10 limiting the differentiation of DC from mono-
cytic precursors. Critically, these APC could not be distinguished
from concurrently infiltrating monocyte-derived InfMØ. Addition-
ally, the presence of the APC populations in naive mice was
unaffected by IL-10-deficiency (Supporting Information Fig. 7).
SES-induced inflammation in Il10–/–mice, compared to wild type
controls, indicated a marked increase in the influx of neutrophils
and InfMØ in the absence of IL-10 (Fig. 6). Three days after SES
injection, InfMØs (CD11bintF4/80intCD11c–CD226–) from Il10–/–
mice exhibited more MHCII expression, compared to the Il10+/+
mice (Fig. 6A). Numbers of neutrophils, InfMØs and APC subsets
were also significantly increased in Il10–/– mice compared to the
controls (Fig. 6B). To control for the exaggerated inflammatory
response observed in the Il10–/– mice, the numbers of APC sub-
sets were expressed as a ratio to InfMØ. While the numbers of
APC were higher in the IL-10-deficient mice compared to controls
(Fig. 6B, middle row); when considered relative to the InfMØ,
the numbers of APC in the knockout mice were lower (Fig. 6B,
lower row). Interestingly, ResMØ had the highest propensity to
produce IL-10 upon ex vivo stimulation (Fig. 6C and D), followed
by all other MØ-like cells with minimal IL-10 production by the
CD11c+CD226low DC-like cells.
Given the previous suggestion [15] that the peritoneal APC
may share common origins with InfMØ, but knowing that these
two cell types could not at that time be distinguished, the
potential of MHCII+ InfMØ for presentation of native antigen
was tested (Fig. 6E and F). MHCII+ InfMØ had typical MØ
appearance (Fig. 6E), but only a minimal capacity to present
ovalbumin to the BO-97.11 hybridoma (Fig. 6F). Acknowledging
the role of CD206 in the uptake of ovalbumin [25] and that the
APC exhibited higher CD206 expression than InfMØ (Fig. 5A,
Supporting Information Fig. 3), the ability of the MHCII+ InfMØ
to present the poorly glycosylated [26] hen egg lysozyme antigen
to the 2G7 hybridoma (Supporting Information Fig. 8) was tested.
These experiments ratified the initial observations of a relatively
poor ability of MHCII+ InfMØ to process and present antigen,
unlike the CD226 and CD11c expressing peritoneal APC subsets.
Discussion
Peritoneal immune alterations are believed to influence outcome
after peritonitis, however, peritoneal APC are very poorly charac-
terized. We recently demonstrated the role of a specific adaptive
immune response in the development of fibrotic tissue damage
following recurrent peritonitis [5]. In this study, our objective
was to characterize the local APC as a first step to the definition
of the evolution of these local immune responses. We defined a
selective surface antigen phenotype for subsets of APC within the
C© 2016 The Authors. European Journal of Immunology published by
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Figure 4. Myeloid cell compositions in the naı¨ve and inflamed peritoneal cavity of Ccr2–/– mice, compared to wild-type Ccr2+/+ mice. Peritoneal
cells from wt and Ccr2+/+ mice were analyzed by flow cytometry. (A) Representative density plots showing peritoneal ResMØ (CD11bhighMHCII−)
and three ‘DC-like’ subsets (CD11bintMHCII+ with CD11clowCD226+, CD11c+CD226+, or CD11c+CD226low) from naı¨ve C57BL/6 CD45.1 (Ccr2+/+) mice
(left panels) and Ccr2–/– mice (right panels). Myelomonocytic cells (MØs and DC) were pregated as CD19−CD11b+F4/80high-to-low cells. Dashed lines
denote the level of isotype controls. In naı¨ve Ccr2–/– mice, the proportion of three ‘DC-like’ subsets within the MØ/DC pool is decreased. Data are
representative of five mice per group from one of two similar experiments. (B) Scatter graphs depicting significantly decreased numbers of all
three ‘DC-like’ subsets in Ccr2–/– mice, compared to Ccr2+/+ mice. Additionally, no differences in total cell number, eosinophils, ResMØ numbers
were noted between Ccr2+/+ and Ccr2–/– naı¨ve mice under naive status. Horizontal lines represent the mean of five mice per group (Symbols
represent individual mice) from one of two independent experiments. Data were analyzed by Student’s t-test. (C) Representative density plots
showing peritoneal ResMØ, InfMØ, and three ‘DC-like’ subsets from 72 h after SES challenge in Ccr2+/+ mice (left panels) and Ccr2–/– mice (right
panels). Cells were gated as described in (A) above. In Ccr2–/– mice, the proportion/number of CD11b+F4/80int-to-low InfMØ/DC decreased, compared
to Ccr2+/+ mice. Data are derived from one of two similar experiments and represent six mice. (D) Scatter plots graphs depicting significantly
decreased numbers of InfMØ and all three ‘DC-like’ subsets in Ccr2–/– mice, compared to Ccr2+/+ mice, at 72 h after SES challenge. Data represent
the mean of six mice per group pooled from two independent experiments. Data were analyzed by Student’s t-test.
peritoneal cavity, permitting the first study of their inflammatory
kinetics, activation and capacity for antigen processing and pre-
sentation.
While we divided the cells into three populations based on
CD226 and CD11c expression for pragmatic reasons, several
observations suggest the existence of two main populations of
APC in the peritoneum (represented by the CD11c+CD226low
and CD11clowCD226+ phenotypes): more evident MerTK expres-
sion on the CD226+ cells compared to its absence on CD11c+
CD226lowcells (Fig. 5A, Supporting Information Fig. 3); a tran-
sient appearance of Ly-6C expression on the CD226+ subpopu-
lations during acute inflammation (Supporting Information Fig.
4A); and a more uniform staining of the CD11c+CD226low cells
with CD209a (Fig. 5).
We investigated the origins of the peritoneal APC. The devel-
opment of DC is mostly dependent on Flt3l [27], so we examined
the presence of myelomonocytic cells in the peritoneal cavities of
Flt3l-deficient mice (Fig. 2). All three APC populations exhibited
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Figure 5. Phenotype and antigen presenta-
tion by peritoneal APC in naı¨ve mice. (A) His-
tograms showing differential expression of sur-
face markers on the defined subsets of peri-
toneal APC in naı¨ve mice. Data are represen-
tative of six mice pooled from two indepen-
dent experiments with C57BL/6 mice. (B) Multi-
color flow cytometry analysis of peritoneal cells
for CD11c, CD209a, and CD226 expression. (C)
Coomassie stained SDS PAGE gel showing the
protein content of EWE (5 μg resolved on a 12%
SDS PAGE gel). Ovalbumin (OVA) (45 KDa) is
the major constituent of egg white. (D) The
ability of the purified cellular subsets to pro-
cess and present EWE on MHCII to BO-97.11
cells was assessed by IL-2 ELISA measurement
in the cell culture supernatants. Data show
mean±SEM of IL-2 production by the BO-97.11
T-cell hybridoma from two independent exper-
iments, which were pooled after normalization
of the data to the peptide pulsed BMDC control.
a marked dependency on Flt3l as expected of cells of the dendritic
cell lineage, but the ResMØ were present in comparable numbers
in the Flt3l-deficient and wild-type mice. To confirm the presence
of DC, we employed DNGR-1+ cell fate mapping using the Clec9a-
Cre to label cells derived from the DC precursors (Fig. 3). Although
ResMØ exhibited minimal YFP labeling and CD103+CD11b– DC
were mostly positive (because of their expression of DNGR-1), the
peritoneal APC exhibit heterogeneous labeling comparable to that
seen in bona-fide DC [21]. Collectively, these data strongly support
the idea that a substantial fraction of the ‘DC-like’ cells are prod-
ucts of the DC lineage, as defined by Guilliams et al. [27]. All three
APC populations also expressed CCR2 and, in contrast to ResMØ,
they exhibited notable reductions in numbers in the absence of
CCR2 (Fig. 4). CCR2-dependency is generally taken to indicate
contribution to the APC populations by the monocyte-lineage.
Using the criteria of Guilliams et al. we can further define the
C© 2016 The Authors. European Journal of Immunology published by
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Figure 6. IL-10 limits the inflammatory response to intraperitoneal SES, but it does not limit the presence of peritoneal APCs. Peritoneal cells from
wild-type and Il10−/− mice with SES-induced peritonitis were analyzed by flow cytometry. (A) Density plots showing the gating of recruited InfMØ
(CD11bintF4/80int/lowTim4−CD11c−CD226−) and the proportion of positive MHCII expression at 72 h post-SES challenge in wild-type (Il10+/+, upper
panels) and IL-10 knockout (Il10−/− lower panels) C57BL/6 mice. Cells were pregated by the exclusion of doublets, F4/80−Ly6G+ neutrophils, and
CD19+ B cells. Tim4 antibody was applied to assure the specific exclusion of themajority of ResMØs (CD11bhighF4/80highTim4+). Comparison of high
MHCII expression of InfMØs between Il10+/+ and Il10−/− mice was shown in the bar graph (far right). Data shown are represented as mean±SEM of
—six to seven mice per group, combined from two independent similar experiments. Data were analyzed by Student’s t-test. (B) Graphs showing
the comparisons of actual numbers of individual peritoneal populations between Il10+/+ and Il10−/− mice at 72-h post-SES challenge. Data were
derived from same animals shown in (A). p values are summarized as follows: **p < 0.01 and ***p < 0.001.(C) Representative density plots depicting
flow-cytometric determination of intracellular IL-10 production from individual subset of peritoneal MØ and APC harvested from C57BL/6 mice
72-h post-SES challenge then stimulated with SES (1:10 dilution). (D) Bar graph showing the comparisons of intracellular IL-10 production among
distinct subsets of peritoneal MØ and APC from 72-h post-SES challenged C57BL/6 mice. Positive intracellular IL-10 production was determined by
comparison with isotype controls. Data represent the mean±SEM of C57BL/6 female mice from one of two identical experiments with five mice
per experiment. Data were analyzed by two-way ANOVA, with Interaction (Int) statistic indicated and post-test analysis of the differences from
ResMØ (asterisks). p values are summarized as follows: ***p < 0.001. (E) Dot plots showing the flow cytometric sorting strategy of peritoneal MHCII+
InfMØs (CD19−Tim4−CD11b+MHCII+CD11c−CD226−) as well as three subsets of peritoneal APC cells from 72-h post-SES challenged C57BL/6 mice.
The CD19–Tim4– population (R1) was gated, before gating on the CD11b+MHC-IIhigh/+ population (R2) and then excluding the three APC subsets
(CD226–CD11c–). The peritoneal APC were purified as previously defined based on CD11c and CD226 expression. The morphology of cytospun
MHCII+ InfMØ is shown below (scale bar represents 30 μm). Data represent two individual experiments (cells were pooled from 10 C57BL/6 for each
experiment). (F) Bar graph depicting the IL-2 production of BO-97.11 cells after culture with the indicated cell subsets and EWE. Data represent the
mean ± SEM of one of two identical experiments, each with three technical replicates.
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nature of the DC population present via marker characterization,
with the cells having the phenotype of conventional or classical
(c)DC2. This is because of their expression of CD11b, CD206, and
CD115 (the latter previously reported [11]) and lack of CD103
and Clec9a (the latter evident from the Immunological Genome
Consortium data: Immgen.org) [27].
The arrival of the peritoneal APC in the tissue is differen-
tially regulated by IL-10, as compared to the bulk population of
inflammatory monocyte-derived MØ. This indicates that during
inflammation, IL-10 preferentially suppresses the inflammatory
response, with a notably reduced impact on APC recruitment. A
recent study of infectious inflammation assessed the regulatory
role of IL-10 on the differentiation of MHCII+ ‘DC’ and MHCII–
MØ [15]. Our data reproduce some observations, showing that
IL-10 regulates MHCII expression by InfMØ during inflamma-
tion. However, with regard to IL-10 preventing differentiation of
DC from a common monocytic-precursor [15], we have shown,
the APC subsets are not only proportionately less increased than
MHCII+ InfMØ in the absence of IL-10, indicating no preferen-
tial restriction of their differentiation, but that their origins are
more complex. Collectively, these studies demonstrate that MHCII
expression by InfMØ is an indicator of the inflammatory process
and the state of their activation. This, along with the recruitment
of these cells, is regulated by IL-10, which may be predominantly
derived fromResMØ. However, the presence of efficient peritoneal
APC during an acute inflammatory response is more independent
of IL-10. This could indicate that strategies aimed at regulating
inflammation through the therapeutic modulation of IL-10 may
have a lesser impact on the development of adaptive immunity,
while prominently regulating InfMØ recruitment and activation
(MHCII expression). The discrete compartmentalization of APC
functions within the tissue has implications for the development of
protective immunity at this site and the potential immune-driven
failure of PD as a therapy, particularly in patients who experience
repeated bouts of infection [5]. Interestingly, like the recruitment
of the APC (this study), immune-driven tissue damage in the peri-




Mice used in this study (C57BL/6, Harlan; C57BL/6.Il10–/–, Jack-
son Laboratory; 129S6/SvEv and 129S6/SvEv.CD45.1 congenic,
our colonies; Ccr2–/– mice: B6.129S4-Ccr2tm1lfc/J, Jackson Labo-
ratory; C57BL/6.CD45.1 (B6.SJL-PtprcaPepcb/BoyJ)mice, Jackson
Laboratory)) were 6–12 week old females. Clec9a+/CreRosa+/EYFP
and Flt3l–/– mice, 9–16 week old females and males, were kindly
provided by Professor Caetano Reis e Sousa (The Francis Crick
Institute, UK). All experiments were performed in accordance with
institutional and United Kingdom Home Office guidelines.
Peritonitis was caused by intraperitoneal administration of
200μL of a cell-free supernatant prepared from a clinical isolate of
S. epidermidis (SES) [18] or administration of zymosan particles
(0.2–2 × 107, as indicated). Mice were sacrificed and peritoneal
cells harvested by lavage using 5 mL ice-cold 5mM EDTA in PBS.
Flow-cytometry
Analysis
Flow-cytometry was performed according to conventional pro-
tocols [20, 28–31]. Cells were incubated in blocking buffer
(5% (v/v) heat-inactivated rabbit serum, 0.5% w/v BSA, 5 mM
EDTA, 2 mM NaN3, 4 μg/mL rat anti-mouse FcɣRII&III (2.4G2)
in PBS) for 30 min at 4°C. Fluorochrome-labeled or biotin-
conjugated antibodies (Supporting Information Table 2) in wash
buffer (0.5% w/v BSA, 5 mM EDTA, 2 mM NaN3 in PBS) were
added. After 30-min incubation at 4°C, cells were washed three
times with wash buffer. When necessary, cells were incubated for
further 30 min at 4°C with fluorochrome-conjugated streptavidin
(Supporting Information Table S2). For intracellular flow cytom-
etry, cells were fixed in 1% formaldehyde (in PBS) for 20 min and
permeabilized with wash buffer containing 0.5% (w/v) saponin
(Sigma) prior to staining as above. Cells were acquired on a Cyan
ADP analyzer, and analyzed with Summit software (Beckman-
Coulter, Fullerton, CA, USA).
Cell sorting
Cells were typically pooled from 10 mice (na¨ıve or 72 h
after intraperitoneal SES) and purified on a FACSAriaTMIII
(BD Bioscience) after staining as above (without NaN3). Cell
purity was confirmed by flow-cytometry. Cytospin preparations
were made using 104 cells (300 rpm for 5 min, Cytospin 3,
Shandon). Slides were stained with Microscopy Hemacolour
(Merck), visualized on a Leica DMLB microscope with DFC490
camera (Leica) and processed using QWin Software (Leica). The
highest cell sort purities were: ResMØ: 98.56%; MHCII+ InfMØ:
99.72%; CD11clowCD226+: 94.29%; CD11c+CD226+: 89.86%;
CD11c+CD226low: 88.89%.
Ex vivo stimulations
Peritoneal cells were washed three times with complete RPMI
medium (RPMI 1640 medium supplemented with 10% heat-
inactivated fetal calf serum, 10 U/mL penicillin and 10 μg/mL
streptomycin). Cells were stimulated in 48-well flat-bottomed
plates (2 × 105/well in 200 μL) in the presence of 0.1% (v/v)
Golgi-plug (BD Biosciences). Stimulations with SES (10% (v/v) in
complete RPMI) or LPS (100 ng/mL), with medium only controls,
were performed in parallel for 6 h (37°C, 5% CO2). The cells were
carefully recovered using cell scrapers and analyzed (see above).
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APC assays
Bone marrow (BM)-derived DC from 129S6SvEv mice were
differentiated in 20 ng/ml GM-CSF for 7 days. B3Z, a CD8+
T-cell hybridoma specific for the ovalbumim257-264 peptide
(SIINFEKL) in the context of Kb, was provided by Nilabh
Shastri (University of California, Berkeley, CA) [32]. BO-
97.11, a CD4+ T-cell hybridoma that responds to the peptide
ovalbumin323-339 (ISQAVHAAHAEINEAGR) presented by I-Ab,
was a gift from Philippa Marrack (National Jewish Center for
Respiratory Medicine, Denver, CO, USA) [33]. Purified APCs
(104 cells) were co-cultured with BO-97.11 cells at a 1:1 ratio
in a 96-well flat-bottom plates in 40μL complete RPMI with or
without 5 mg/ml egg white extract (EWE, see below). In control
experiments 5 × 104 BMDC, were used in a 1:1 ratio with either
B3Z or BO97.11 cells with EWE or ovalbumin. To ensure antigen
internalization and processing was occurring, BMDC were fixed
with 1% paraformaldehyde for 10 min, which was then quenched
with an equal volume of 0.1M glycine in PBS (pH 7.0) for 10 min.
APC were washed three times with medium before co-culture with
the T cells for 24 h (37°C, 5% CO2). The ovalbumin peptides indi-
cated above (2μM)were used as controls. IL-2 in the supernatants
was measured by ELISA (BD OptEIA, BD Biosciences).
EWE
To prepare EWE [24], egg white was recovered through a small
hole in the end of a fresh chicken egg and diluted to 50 mL with
PBS. The egg white was repeatedly passed through decreasing
needle sizes (21G to 25G) and then a 0.2 μm filter before storage
at −80°C. A sample of 5 μg was separated on a 12% SDS PAGE
gel under reducing conditions and stained with Coomassie blue.
Statistical analysis
Statistical analyses (see appropriate text) were achieved with
GraphPad Prism. p values, when summarized, are as follows: *p <
0.05, **p < 0.01, and ***p < 0.001.
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